Analytical Data
-
Gene name
IL-21R
- Application
-
Alternative Names
CD360; NILR; Novel interleukin receptor
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
> 95% as determined by SDS-PAGE.
-
Uniprot
Q9HBE5
-
Expression Region
Leu23~Leu185
-
Molecular Weight
23kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Interleukin-21 receptor (IL-21R) is a crucial component of the immune system, playing a significant role in regulating the differentiation and activity of various immune cells, including T and B lymphocytes. Understanding the function of IL-21R is essential for elucidating its involvement in immune responses, particularly in the context of autoimmune diseases, infections, and cancer. The recombinant IL-21R protein has emerged as a valuable tool for research, enabling scientists to investigate its signaling pathways, receptor interactions, and biological effects. By producing and purifying IL-21R as a recombinant protein, researchers can conduct in vitro studies to further dissect the mechanisms by which IL-21R influences immune cell behavior and how its dysregulation may lead to pathological conditions. Furthermore, recombinant IL-21R can serve as a potential therapeutic target, paving the way for innovative treatment strategies aimed at modulating immune responses in various diseases. Overall, the research on IL-21R recombinant protein contributes to a deeper understanding of immune modulation and holds promise for advancing immunotherapy and targeted therapies.
